Enveric Biosciences, Inc. (ENVB)

1.47 +0.06 (+4.26%) USD  |  NASDAQ  |  Aug 25, 16:00
1.47 0.00 (0.00%) After-Hours: 18:56
More

Enveric Biosciences Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for ENVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2024 --
April 02, 2024 --
March 31, 2024 --
December 31, 2023 --
December 29, 2023 --
Date Value
November 20, 2023 --
October 03, 2023 --
September 30, 2023 --
August 24, 2023 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
LENZ Therapeutics, Inc. Upgrade
Impact BioMedical, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade